Through bioinformatics analysis probing potential mechanisms underlying disparate prognoses in HCC patients, we unearthed a robust association between ARGs-induced differential prognosis and the activation of the PI3K/AKT/mTOR signaling axis. The gene discussed is MTOR; the disease is hepatocellular carcinoma.